Cargando…

Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis

PURPOSE: We investigated the prognostic impact of discordance between the receptor status of primary breast cancers and corresponding metastases. METHODS: A total 144 patients with breast cancer and distant metastasis were investigated. The estrogen receptor (ER), progesterone receptor (PR), and hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Hee-Chul, Han, Wonshik, Moon, Hyeong-Gon, Park, In-Ae, Noh, Dong-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053311/ https://www.ncbi.nlm.nih.gov/pubmed/27721876 http://dx.doi.org/10.4048/jbc.2016.19.3.268

Ejemplares similares

Comment to “Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis”
por: Altundag, Kadri
Publicado: (2016)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
por: Piras, F., et al.
Publicado: (2011)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer
por: Handa, Tadashi, et al.
Publicado: (2019)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
por: Kim, Ryong Nam, et al.
Publicado: (2018)

Reliability of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Han, Ahram, et al.
Publicado: (2013)

Location of Triple-Negative Breast Cancers: Comparison with Estrogen Receptor-Positive Breast Cancers on MR Imaging
por: Kim, Won Hwa, et al.
Publicado: (2015)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment
por: Yoo, Tae-Kyung, et al.
Publicado: (2017)

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
por: Jin, Jia, et al.
Publicado: (2018)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Reduced proliferation in breast cancer cells contacting the neighboring adipocytes in human breast cancer tissues
por: Ryu, Han Suk, et al.
Publicado: (2015)

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014)

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
por: Luo, Rong-Zhen, et al.
Publicado: (2013)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

MAT2B expression correlates with poor prognosis in triple-negative breast cancer
por: Xu, Jin, et al.
Publicado: (2019)

circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
por: Yu, Jinling, et al.
Publicado: (2020)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Kim, So-Woon, et al.
Publicado: (2021)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2015)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing
por: Yoo, Tae-Kyung, et al.
Publicado: (2022)

Low Rates of Additional Cancer Detection by Magnetic Resonance Imaging in Newly Diagnosed Breast Cancer Patients Who Undergo Preoperative Mammography and Ultrasonography
por: Kim, Jisun, et al.
Publicado: (2014)

CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis
por: Cerqueira, Otto L.D., et al.
Publicado: (2015)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
por: Daulat, Avais M., et al.
Publicado: (2019)

Comparative characterization of 3D chromatin organization in triple-negative breast cancers
por: Kim, Taemook, et al.
Publicado: (2022)

Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis
por: Yoo, Tae-Kyung, et al.
Publicado: (2018)

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
por: Lips, E H, et al.
Publicado: (2013)

Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based Study
por: You, Jee Man, et al.
Publicado: (2015)

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
por: Han, Tao, et al.
Publicado: (2015)

Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer
por: Cheng, Guangcun, et al.
Publicado: (2016)

Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
por: Li, Jing-ping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m1vo5nltm653fhs1dea6s9om1q